Suvorexant
Back to searchMolecule Structure
Scientific Name
Suvorexant
Description of the Drug
Suvorexant is a orexin receptor antagonist used to treat insomnia that is characterized by difficulties with sleep onset and/or sleep maintenance.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09034
http://www.drugbank.ca/drugs/DB09034
Brand Name(s)
Belsomra
Company Owner(s)
Merck Sharp And Dohme Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Orexin receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL3307226 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1586289 | |
| DrugBank | DB09034 | |
| PubChem: Thomson Pharma | 56264110 | |
| PubChem | 24965990 | |
| LINCS | LSM-45422 | |
| Nikkaji | J2.846.988H | |
| PDBe | SUV | |
| BindingDB | 50318701 | |
| EPA CompTox Dashboard | DTXSID90145616 | |
| DrugCentral | 4881 | |
| ChemicalBook | CB62589660 | CB92599932 |
| Guide to Pharmacology | 2890 | |
| rxnorm | SUVOREXANT | BELSOMRA |
| PubChem: Drugs of the Future | 99431637 | |
| ChEBI | 82698 | |
| ZINC | ZINC000049036447 |
